We provide 1 form of Erdafitinib
Erdafitinib
1346242-81-6
|
446.243
|
4.271
Erdafitinib is a fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma.
JNJ-42756493 | erdafitinib
Erdafitinib is a fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma.
JNJ-42756493 | erdafitinib
$55/5 mg
(EBC)
1
We provide 0 compound for Erdafitinib